Yilun Deng1, Bi Zhao1, Bing Wei2, Shihong Zhang3, Ming Liu4. 1. Department of Neurology, West China Hospital, Sichuan University, Chengdu, Sichuan, China. 2. Department of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan, China. 3. Department of Neurology, West China Hospital, Sichuan University, Chengdu, Sichuan, China. zsh9@hotmail.com. 4. Department of Neurology, West China Hospital, Sichuan University, Chengdu, Sichuan, China. wyplmh@hotmail.com.
Abstract
BACKGROUND: Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) is an inflammatory disorder with unclear causes. Paraneoplastic etiology may be a cause. We report a case of CLIPPERS with parotid carcinoma. CASE PRESENTATION: A 54-year-old man with a history of lymphoma was hospitalized with a pontocerebellar syndrome. Brain MRI revealed that the pons and cerebellum were "peppered" with punctate and curvilinear enhancement lesions that supported the diagnosis of CLIPPERS. The relapse of lymphoma was excluded by a further cerebellum biopsy revealing predominantly CD3+ T cells in white matter. The patient was relieved after pulse therapy with intravenous methylprednisolone and a large dose of corticosteroids, but he complained of a worsening gait problem when corticosteroids were tapered to a lower dose. Although the clinical symptoms gradually improved again by increasing the dosage of corticosteroids with Azathioprine, the patient still had a slight unsteady gait during follow-up. At the 7-month follow-up, a parotid mass was detected by MRI and was verified as carcinoma by biopsy. After resection of parotid carcinoma, the residual symptoms and previous MRI lesions disappeared, and no relapse occurred. CONCLUSIONS: CLIPPERS may not be a distinct nosologic entity but an overlapping diagnosis with other diseases. Some cases of CLIPPERS might be a subtype of paraneoplastic neurological syndromes (PNS) due to the similar mechanism of antibody-mediated encephalitis. Tumor screening and serum paraneoplastic autoantibody tests are recommended for patients with CLIPPERS, especially for those who relapse when corticosteroids treatment is stopped or tapered.
BACKGROUND:Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) is an inflammatory disorder with unclear causes. Paraneoplastic etiology may be a cause. We report a case of CLIPPERS with parotid carcinoma. CASE PRESENTATION: A 54-year-old man with a history of lymphoma was hospitalized with a pontocerebellar syndrome. Brain MRI revealed that the pons and cerebellum were "peppered" with punctate and curvilinear enhancement lesions that supported the diagnosis of CLIPPERS. The relapse of lymphoma was excluded by a further cerebellum biopsy revealing predominantly CD3+ T cells in white matter. The patient was relieved after pulse therapy with intravenous methylprednisolone and a large dose of corticosteroids, but he complained of a worsening gait problem when corticosteroids were tapered to a lower dose. Although the clinical symptoms gradually improved again by increasing the dosage of corticosteroids with Azathioprine, the patient still had a slight unsteady gait during follow-up. At the 7-month follow-up, a parotid mass was detected by MRI and was verified as carcinoma by biopsy. After resection of parotid carcinoma, the residual symptoms and previous MRI lesions disappeared, and no relapse occurred. CONCLUSIONS:CLIPPERS may not be a distinct nosologic entity but an overlapping diagnosis with other diseases. Some cases of CLIPPERS might be a subtype of paraneoplastic neurological syndromes (PNS) due to the similar mechanism of antibody-mediated encephalitis. Tumor screening and serum paraneoplastic autoantibody tests are recommended for patients with CLIPPERS, especially for those who relapse when corticosteroids treatment is stopped or tapered.
Authors: Neil G Simon; John D Parratt; Michael H Barnett; Michael E Buckland; Ruta Gupta; Michael W Hayes; Lynette T Masters; Stephen W Reddel Journal: J Neurol Neurosurg Psychiatry Date: 2011-11-05 Impact factor: 10.154
Authors: W Oliver Tobin; Yong Guo; Karl N Krecke; Joseph E Parisi; Claudia F Lucchinetti; Sean J Pittock; Jay Mandrekar; Divyanshu Dubey; Jan Debruyne; B Mark Keegan Journal: Brain Date: 2017-09-01 Impact factor: 13.501
Authors: Hjalmar J De Graaff; Mike P Wattjes; Annemieke J Rozemuller-Kwakkel; Axel Petzold; Joep Killestein Journal: JAMA Neurol Date: 2013-07 Impact factor: 18.302